期刊文献+

热熔挤出法制备尼美舒利固体分散体 被引量:6

Preparation of Nimesulide Solid Dispersion by Hot Melt Extrusion Technology
原文传递
导出
摘要 目的采用热熔挤出技术制备难溶性药物尼美舒利固体分散体,提高其溶出速率。方法以共聚维酮(PVP-VA64,Kol-lidon VA64)、聚维酮(PVPK30)或聚乙烯醇-聚乙二醇(3∶1)接枝共聚物(Kollicoat IR)为亲水性载体材料,使用双螺杆热熔挤出机制备尼美舒利固体分散体,通过差示扫描量热法(DSC)、X射线衍射法(XRD)、傅立叶红外光谱(FTIR)和体外溶出度测定来表征和评价所制备的固体分散体。结果以共聚维酮为载体制备的尼美舒利固体分散体药物溶出最快,在pH 7.4的磷酸盐缓冲液中10 min溶出达到81%,远快于物理混合物(1 h时只有37%)。X射线衍射图谱显示药物晶体衍射峰消失,差示扫描量热图谱显示药物晶体吸热峰消失,提示药物是以无定形态分散在载体材料中。结论热熔挤出加工技术适用于制备尼美舒利-共聚维酮固体分散体,药物是以无定形态分散在载体中,溶出度得到显著提高。 OBJECTIVE To improve the in vitro dissolution of nimesulide by preparing nimesulide solid dispersion with hot melt extrusion (HME) technology. METHODS Using PYP-VA64 ,PYP K30 or PYA-PEG (Kollicoat IR) as hydrophihc carrier,nimesu- lide solid dispersion was prepared by hot melt extrusion and characterized by drug dissolution, DSC, XRD and FTIR. RESULTS Nimesulide exhibited rapid in vitro dissolution from the solid dispersion using PVP-VA64 as cartier. The cumulative release rate was 81% in 10 min, much faster than its physical mixture (only 37% in 1 h). The results of DSC and FTIR showed that nimesulide was amorphously dispersed in the carrier. CONCLUSION Hot melt extrusion technology is suitable for preparing nimesulide-PVP-VA64 solid dispersion, which can significantly increase drug dissolution.
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第3期185-190,共6页 Chinese Pharmaceutical Journal
基金 北京市自然科学基金资助项目(7092052)
关键词 热熔挤出技术 固体分散体 尼美舒利 共聚维酮 溶出度 : hot melt extrusion solid dispersion nimesnlide PVP-VA64 dissolution
  • 相关文献

参考文献1

二级参考文献11

  • 1Nakamichi K, Nakano T, Yasuura H. The role of the kneading paddle and the effects of screw revolution speed and water content on the preparation of solid dispersions using a twin-screw extruder[J]. Int J Pharm ,2002,241(2) :203 - 211.
  • 2Hulsmann S, Backensfeld T, Keitel S, et al. Melt extrusion-an alternative method for enhancing the dissolution rate of 17β-estradiol hemihydrate [J]. Eur J Pharm Biopharm, 2000,49(3) :237 - 242.
  • 3Perissutti B, Michael B, Newton JM, et al. Preparation of extruded carbamazepine and PEG4000 as a potential rapid release dosage form [J]. Eur J Pharm B iopharm, 2002,53 (1): 125 - 132.
  • 4Verreck G, Six K, Mooter GV, et al. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion-partI [ J ]. lnt J Pharm, 2003,251 (1-2): 165 - 174.
  • 5Crowley MM, Schroeder B, Fredersdorf A, et al. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion[J]. Int J Pharm, 2004,269(2): 509 - 522.
  • 6Mehuys E, Vervaet C, Remon JP. Hot-melt extruded ethylcellulose cylinders containing a HPMC-Gelucire(R) core for sustained drug delivery [ J ]. J Controlled Release, 2004, 94 (2-3): 273 - 280.
  • 7Repka MA, Gutta K, Prodduturi S, et al. Characterization of cellulosic hot-melt extruded films containing lidocaine [ J ]. Eur J Pharm Biopharm ,2005,59( 1 ): 189 - 196.
  • 8Crowley MM, Fredersdorf A, Schroeder B, et al. The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films[ J]. Eur J Pharm Sci, 2004,22 ( 5 ): 409 -418.
  • 9Forster A, Hempenstall J, Tucker I, et al. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis [ J ]. Int J Pharm, 2001,226(1-2): 147 - 161.
  • 10Breitenbach J. Melt extrusion: from process to drug delivery technology [J]. Eur J Pharm Biopharm ,2002,54(2): 107 - 117.

共引文献24

同被引文献40

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部